The study to assess the incidence of nephrogenic systemic fibrosis (NSF) before and after gadobenate dimeglumine in patient with renal insufficiency compared with gadodiamide.
Phase of Trial: Phase IV
Latest Information Update: 16 Nov 2017
At a glance
- Drugs Gadodiamide (Primary) ; Gadoterate-meglumine (Primary)
- Indications Cardiovascular disorders; Nephrogenic systemic fibrosis
- Focus Therapeutic Use
- 16 Nov 2017 New trial record